retatrutide mechanism triple agonist glp-1 gip glucagon retatrutide receptor LY3437943, a novel glucagon, GIP, and for is retatrutide a peptide or

High demand for Ozempic and Wegovy outstripped manufacturing capacity, creating supply gaps that compounding pharmacies were legally permitted to fill under federal law

Appetite suppression becomes consistent

Given their widespread use and the frequency with which dermatology clinicians encounter patients taking GLP-1s, we felt it was important to characterize reported cutaneous adverse events at a population level

Full peer-reviewed data will be important to validate durability and long-term safety outcomes

Week-by-Week Timeline: What to Expect Week 1: The Adjustment Phase Most people notice GI effects within hours to a few days of their initial injection or oral dose